GB1153767A - Improvements in or relating to Amitotic Therapeutic Composition Administrable by the Topical Route - Google Patents

Improvements in or relating to Amitotic Therapeutic Composition Administrable by the Topical Route

Info

Publication number
GB1153767A
GB1153767A GB35962/67A GB3596267A GB1153767A GB 1153767 A GB1153767 A GB 1153767A GB 35962/67 A GB35962/67 A GB 35962/67A GB 3596267 A GB3596267 A GB 3596267A GB 1153767 A GB1153767 A GB 1153767A
Authority
GB
United Kingdom
Prior art keywords
amitotic
relating
therapeutic composition
topical
topical route
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB35962/67A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CASSENNE LAB SA
Original Assignee
CASSENNE LAB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CASSENNE LAB SA filed Critical CASSENNE LAB SA
Publication of GB1153767A publication Critical patent/GB1153767A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB35962/67A 1966-08-23 1967-08-04 Improvements in or relating to Amitotic Therapeutic Composition Administrable by the Topical Route Expired GB1153767A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR73820A FR6224M (ja) 1966-08-23 1966-08-23

Publications (1)

Publication Number Publication Date
GB1153767A true GB1153767A (en) 1969-05-29

Family

ID=8615777

Family Applications (1)

Application Number Title Priority Date Filing Date
GB35962/67A Expired GB1153767A (en) 1966-08-23 1967-08-04 Improvements in or relating to Amitotic Therapeutic Composition Administrable by the Topical Route

Country Status (2)

Country Link
FR (1) FR6224M (ja)
GB (1) GB1153767A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013155584A1 (pt) 2012-04-20 2013-10-24 Biolab Sanus Farmacêutica Ltda. Composição farmacêutica tópica, processo de produção da composição farmacêutica tópica, uso da composição farmacêutica tópica e método de tratamento tópico de psoriase, dermatite atópica ou eczemas crônicos

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1275369A1 (en) * 2001-07-10 2003-01-15 Goldschmidt AG Folic acid containing personal care product

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013155584A1 (pt) 2012-04-20 2013-10-24 Biolab Sanus Farmacêutica Ltda. Composição farmacêutica tópica, processo de produção da composição farmacêutica tópica, uso da composição farmacêutica tópica e método de tratamento tópico de psoriase, dermatite atópica ou eczemas crônicos

Also Published As

Publication number Publication date
FR6224M (ja) 1968-08-05

Similar Documents

Publication Publication Date Title
ES8100883A1 (es) Procedimiento para la produccion de un preparado farmaceuti-co
IE43693L (en) Androstane derivatives
JPS5699412A (en) Rosemary aciddcontaining pharmaceutic product
US3777020A (en) Psoriasis treatment with mycophenolic acid
IE32453B1 (en) Pteridine derivatives
GB1153767A (en) Improvements in or relating to Amitotic Therapeutic Composition Administrable by the Topical Route
IE37250L (en) Triazolobenzodiazepines
GB1248429A (en) 4-phenyl-quinazolinone derivative
GB1152627A (en) Improvements in or relating to Oxazole Derivatives
GB1493237A (en) Pharmaceutical preparations for the treatment of hyperuricacidemia
GB1264509A (ja)
GB976096A (en) Pharmaceutical compositions
GB1125924A (en) Organic bismuth derivative
IE43994L (en) Diphenylmethanes.
GB1215152A (en) Biguanide derivatives and pharmaceutical preparations containing them
GB1279380A (en) Improvements in or relating to hydantoins and compositions thereof
GB1129018A (en) Improvements in or relating to therapeutic composition, useful, in particular, as antiinflammatory composition and in ophthalmology
GB1157662A (en) Improvements in or relating to Pharmaceutical Compositions
GB1142757A (en) Therapeutic compositions
GB1492383A (en) Therapeutic composition
Reiches Angular stomatitis treated with silicote ointment
SU374086A1 (ru) ЛЕКАРСТВЕННОЕ СРЕДСТВО''^ --''ОсНАЯ'•'^^^bju;r---jc^'-;^..':. :0 •--.:А |:'*''~'"~~ •' - ——«-.«aSJ^iH.
IE32617L (en) Pharmaceutical composition
GB1050396A (ja)
GB1106580A (en) A composition for the topical treatment of muscular pains